Bristol Gate Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap-on
SNA
|
+$26.7M |
| 2 |
Cintas
CTAS
|
+$26M |
| 3 |
DuPont de Nemours
DD
|
+$26M |
| 4 |
Agilent Technologies
A
|
+$24.9M |
| 5 |
Hormel Foods
HRL
|
+$8.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$26.2M |
| 2 |
Amphenol
APH
|
+$25.8M |
| 3 |
Lincoln National
LNC
|
+$24.6M |
| 4 |
Cencora
COR
|
+$24.5M |
| 5 |
UnitedHealth
UNH
|
+$1.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.38% |
| 2 | Industrials | 18.86% |
| 3 | Healthcare | 18.75% |
| 4 | Consumer Staples | 15.28% |
| 5 | Technology | 9.39% |
Similar funds
Bristol Gate Capital Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Bristol Gate Capital Partners held 25 positions worth $559M, up 3.4% from $541M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bristol Gate Capital Partners deployed $28.4M of net new capital in Q2 2016, opening 4 new positions and adding to 11 existing holdings. Its largest new stake was Snap-on: 167,949 shares worth $26.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was UnitedHealth, an estimated $1.44M trimmed.
- Bristol Gate Capital Partners's largest Q2 2016 buy was Snap-on: 167,949 shares worth $26.5M.
- Bristol Gate Capital Partners added most to Hormel Foods in Q2 2016, an estimated $8.08M increase.
- Bristol Gate Capital Partners's biggest Q2 2016 reduction was UnitedHealth, cutting an estimated $1.44M.
- Bristol Gate Capital Partners fully exited Danaher in Q2 2016, selling an estimated $26.2M.
- Bristol Gate Capital Partners's ten largest holdings make up 49% of its $559M portfolio in Q2 2016.
- Bristol Gate Capital Partners opened 4 new positions and closed 4 in Q2 2016.
- Bristol Gate Capital Partners's portfolio value rose 3.4% quarter-over-quarter to $559M.
Based on Bristol Gate Capital Partners's 13F filing for Q2 2016, filed 29 Jul 2016.